OpenReview.net
  • Login

Daniel Miles

Pronouns: he/him

Employee, Software Team, Iambic Therapeutics

  • Joined August 2025

Names

Daniel Miles (Preferred)
  • Suggest Name

Emails

****@gmail.com (Confirmed)
  • Suggest Email

Personal Links

Homepage
  • Suggest URL

Career & Education History

employee
Software Team, Iambic Therapeutics (iambic.ai)
2022 – Present
 
Undergrad student
College of Natural Sciences, Colorado State University (colostate.edu)
2000 – 2005
 
  • Suggest Position

Advisors, Relations & Conflicts

No relations added

  • Suggest Relation

Expertise

No areas of expertise listed

  • Suggest Expertise

Publications

  • Scaling Multi-Modal and Multi-Task Transformers for Small Molecule Drug Discovery

    David S. Farina Jr, Sai Krishna Sirumalla, Michiel J.M. Niesen, Daniele A. Di Cesare, Felipe Costa Farias, Michael B. O'Connor, Marcelo Gomes Pereira de Lacerda, Orion Walker Dollar, Peter Bygrave, Thomas Dresselhaus, Zhuoran Qiao, Rishi Shah, Jason Swails, Daniel Miles, Oliver Feighan, Stephen Opalenski, Wallace Derricotte, Feizhi Ding, Matthew Welborn, Fred Manby et al. (1 additional authors not shown)
    • NeurIPS2025-AI4Science Poster
    • Readers: Everyone

Co-Authors

  • Daniele A. Di Cesare
  • David S. Farina Jr
  • Feizhi Ding
  • Felipe Costa Farias
  • Fred Manby
  • Jason Swails
  • Marcelo Gomes Pereira de Lacerda
  • Matthew Welborn
  • Michael B. O'Connor
  • Michiel J.M. Niesen
  • Oliver Feighan
  • Orion Walker Dollar
  • Peter Bygrave
  • Rishi Shah
  • Sai Krishna Sirumalla
  • Stephen Opalenski
  • Thomas Dresselhaus
  • Thomas Miller
  • Wallace Derricotte
  • Zhuoran Qiao
  • About OpenReview
  • Hosting a Venue
  • All Venues
  • Contact
  • Sponsors
  • Donate
  • Frequently Asked Questions
  • Terms of Use
  • Privacy Policy
  • About OpenReview
  • Hosting a Venue
  • All Venues
  • Sponsors
  • Frequently Asked Questions
  • Contact
  • Donate
  • Terms of Use
  • Privacy Policy

OpenReview is a long-term project to advance science through improved peer review with legal nonprofit status. We gratefully acknowledge the support of the OpenReview Sponsors. © 2025 OpenReview